Cargando…

Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients

BACKGROUND: This study aimed to evaluate the concordance of oncogenic driver mutations between tumor tissues and circulating tumor DNA (ctDNA) in patients with lung cancer. In addition, this study attempted to reveal the clinical utility of ctDNA in lung cancer treatment. METHODS: Recurrent or metas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sheehyun, Kim, Sungjae, Kim, Se Hyun, Jung, Eun Hee, Suh, Koung Jin, Kim, Yu Jung, Kwon, Nak-Jung, Kim, Hyojin, Chung, Jin-Haeng, Lee, Jong Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326792/ https://www.ncbi.nlm.nih.gov/pubmed/37425402 http://dx.doi.org/10.21037/tlcr-22-912

Ejemplares similares

Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
por: Kim, Hyojin, et al.
Publicado: (2022)

Tumor LAG‐3 and NY‐ESO‐1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non‐small cell lung cancer
por: Jung, Eun Hee, et al.
Publicado: (2021)

A Comprehensive Comparative Analysis of the Histomorphological Features of ALK-Rearranged Lung Adenocarcinoma Based on Driver Oncogene Mutations: Frequent Expression of Epithelial-Mesenchymal Transition Markers than Other Genotype
por: Kim, Hyojin, et al.
Publicado: (2013)

Human Leukocyte Antigen Class I and Programmed Death-Ligand 1 Coexpression Is an Independent Poor Prognostic Factor in Adenocarcinoma of the Lung
por: Han, Yeon Bi, et al.
Publicado: (2019)

Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI Resistance
por: Ahn, Hyein, et al.
Publicado: (2018)

PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
por: Kim, Hyojin, et al.
Publicado: (2017)

Heterotopic Pancreas in Omphalomesenteric Duct Remnant Results in Persistent Umbilical Discharge
por: Park, Eunhyang, et al.
Publicado: (2014)

Evaluation of low-pass genome sequencing in polygenic risk score calculation for Parkinson’s disease
por: Kim, Sungjae, et al.
Publicado: (2021)

Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
por: Jung, Ji-Jung, et al.
Publicado: (2023)

Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
por: Shin, Junghoon, et al.
Publicado: (2019)

Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation
por: Chang, Jae Won, et al.
Publicado: (2016)

The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Yang, Jieun, et al.
Publicado: (2022)

Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group
por: Kim, Hyojin, et al.
Publicado: (2014)

Clinicopathological analysis and prognostic significance of programmed cell death-ligand 1 protein and mRNA expression in non-small cell lung cancer
por: Kim, Hyojin, et al.
Publicado: (2018)

PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells
por: Lee, Hyun Jung, et al.
Publicado: (2020)

Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors
por: Kang, Minsu, et al.
Publicado: (2022)

PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
por: Kim, Hyojin, et al.
Publicado: (2019)

Correction of acknowledgments: PD-L1 testing in non-small cell lung cancer: past, present, and future
por: Kim, Hyojin, et al.
Publicado: (2020)

Biomarker testing of cytology specimens in personalized medicine for lung cancer patients
por: Kim, Hyojin, et al.
Publicado: (2022)

Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing
por: Lee, Jeonghyo, et al.
Publicado: (2022)

Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma
por: Kwon, Soohyeon, et al.
Publicado: (2020)

Efficacy of Olaparib in Treatment-Refractory, Metastatic Breast Cancer with Uncommon Somatic BRCA Mutations Detected in Circulating Tumor DNA
por: Yoon, Jung-Ki, et al.
Publicado: (2023)

A Rare Case of Multiple Nevoid Hypertrichosis with Atrial Septal Defect
por: Kim, Hyojin, et al.
Publicado: (2020)

Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
por: Cha, Yongjun, et al.
Publicado: (2023)

FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells
por: Choi, Eun Jung, et al.
Publicado: (2015)

Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer
por: Park, Sehhoon, et al.
Publicado: (2022)

A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients
por: Kim, Yu Jung, et al.
Publicado: (2022)

Validity of Diagnostic Codes for Identification of Psoriasis Patients in Korea
por: Ham, Seung Pil, et al.
Publicado: (2020)

Performance of clinician prediction of survival in oncology outpatients with advanced cancer
por: Kim, Yu Jung, et al.
Publicado: (2022)

R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
por: Lee, Ji Yun, et al.
Publicado: (2021)

Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer
por: Kim, Sang-A, et al.
Publicado: (2021)

Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients
por: Gwark, Sungchan, et al.
Publicado: (2020)

Palisaded encapsulated neuroma on the lower lip: a case report
por: Seol, Jung Eun, et al.
Publicado: (2021)

Publisher Correction: Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients
por: Gwark, Sungchan, et al.
Publicado: (2021)

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients
por: Heo, Ja Yoon, et al.
Publicado: (2021)

Reliability and Validity of Alcohol Use Disorder dentification Test-Korean Revised Version for Screening At-risk Drinking and Alcohol Use Disorders
por: Kim, Chang-Gi, et al.
Publicado: (2014)

Effects of an Alcohol-Related Harm Prevention Program among Out-of-School Female Adolescents
por: Park, Hyojin, et al.
Publicado: (2021)

Prevalence of Congenital Coronary Artery Anomalies of Korean Men Detected by Coronary Computed Tomography
por: Park, Jae Hyun, et al.
Publicado: (2013)

MiR-4435 is an UQCRB-related circulating miRNA in human colorectal cancer
por: Hong, Ji Won, et al.
Publicado: (2020)

Construction of an MRI-based decision tree to differentiate autoimmune and autoinflammatory inner ear disease from chronic otitis media with sensorineural hearing loss
por: Lee, Boeun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5f54uguig0tqnel2nhbvuc2fl6